← back to search

Mei‐Yu Hsu

Tzu Chi Foundation · TW
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Cells and Metastasis, Angiogenesis and VEGF in Cancer, Cell Adhesion Molecules Research, and melanin and skin pigmentation.
h-index
22
citations
2,590
works
62
NIH funding
primary concept
email

Recent publications

Notch3 signaling-mediated melanoma–endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis
Laboratory Investigation 2017cited by 32position: firstdoi
Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma
Cancer Research 2015cited by 99position: lastdoi
CD133+ Melanoma Subpopulations Contribute to Perivascular Niche Morphogenesis and Tumorigenicity through Vasculogenic Mimicry
Cancer Research 2012cited by 106position: lastdoi
Targeting CD20 in Melanoma Patients at High Risk of Disease Recurrence
Molecular Therapy 2012cited by 83position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Moon Hee Yang · Brigham and Women's Hospital2 papers (2015–2017)Caroline I. Schnegg · University of North Carolina at Chapel Hill2 papers (2015–2017)Chiou-Yan Lai · Harvard University2 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012)Meenhard Herlyn · The Wistar Institute1 papers (2012–2012)Byungwoo Ryu · Georgetown University1 papers (2017–2017) · 1 papers (2012–2012)Katharina Grabmeier‐Pfistershammer · Medical University of Vienna1 papers (2012–2012)Patrick M. Brunner · Icahn School of Medicine at Mount Sinai1 papers (2012–2012)Wolfgang Bauer · Universitätszahnklinik Wien1 papers (2012–2012)Soonyean Hwang · Dana-Farber Cancer Institute1 papers (2017–2017)Stephan N. Wagner · National Institute of Allergy and Infectious Diseases1 papers (2012–2012) · 1 papers (2012–2012)Rhoda M. Alani · Boston University1 papers (2017–2017)Georg Stingl · National Institute of Allergy and Infectious Diseases1 papers (2012–2012)Subrata Ghosh · Institute of Ismaili Studies1 papers (2015–2015)Brian E. Schwartz · VistaGen Therapeutics (United States)1 papers (2012–2012) · 1 papers (2012–2012)